PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma

PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) comprise a group of malignant tumors arising from the squamous epithelium of the oral cavity, pharynx, and larynx. HNSCC is the 6th most common cancer in the world, with approximately 650,000 new cases and 400,000 deaths annually. Although survival rates...

Full description

Bibliographic Details
Main Authors:	Siming Gong, Changwu Wu, Yingjuan Duan, Jinfei Fu, Yuling Wang, Hao Wu, Bixi Zhang, Juyu Tang, Panfeng Wu
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	Heliyon
Subjects:	Head and neck squamous cell carcinoma PLODs Prognostic Tumor microenvironment Immune infiltration Immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023006862

Similar Items

PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma
by: Siming Gong, et al.
Published: (2022-04-01)

A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3)
by: Siming Gong, et al.
Published: (2021-09-01)

Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer
by: Chen R, et al.
Published: (2023-02-01)

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
by: Yawei Sun, et al.
Published: (2021-12-01)

Tumor Microenvironment in Head and Neck Squamous Cell Carcinomas
by: Görkem Eskiizmir
Published: (2015-09-01)

PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression
by: Nina Kreße, et al.
Published: (2022-05-01)

Exploring the frontiers: tumor immune microenvironment and immunotherapy in head and neck squamous cell carcinoma
by: Shaokun Liu, et al.
Published: (2024-01-01)

Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma
by: Congxian Lu, et al.
Published: (2023-11-01)

A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
by: Huili Wu, et al.
Published: (2022-07-01)

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
by: Fan Ye, et al.
Published: (2022-10-01)

Immunotherapy in head and neck squamous cell carcinoma: An updated review
by: K. Parmar, et al.
Published: (2022-01-01)

Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma
by: Lei Dong, et al.
Published: (2023-03-01)

Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma
by: Zixuan Hu, et al.
Published: (2022-09-01)

Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma
by: Lingfei Wan, et al.
Published: (2023-08-01)

A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC
by: Yinghe Ding, et al.
Published: (2023-01-01)

Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
by: Toyaja Jadhav, et al.
Published: (2024-01-01)

Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma
by: Baoai Han, et al.
Published: (2023-10-01)

CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study
by: Chunhong Li, et al.
Published: (2022-09-01)

Tertiary lymphoid structures in head and neck squamous cell carcinoma
by: Jing Zhu, et al.
Published: (2024-06-01)

The relationship between PLOD1 expression level and glioma prognosis investigated using public databases
by: Lei Tian, et al.
Published: (2021-05-01)

Metabolism-associated molecular classification and prognosis signature of head and neck squamous cell carcinoma
by: Mengxian Jiang, et al.
Published: (2024-03-01)

Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy
by: Habib Sadeghirad, et al.
Published: (2023-04-01)

A multifaceted and feasible prognostic model of amino acid metabolism-related genes in the immune response and tumor microenvironment of head and neck squamous cell carcinomas
by: Wei Li, et al.
Published: (2022-10-01)

The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment
by: Ye Zhang, et al.
Published: (2023-05-01)

The characteristics and clinical relevance of tumor fusion burden in head and neck squamous cell carcinoma
by: Lirui He, et al.
Published: (2023-01-01)

Recent advances and prospect in immune microenvironment and its mechanisms of function in head and neck squamous cell carcinoma
by: ZHANG Shaoqiu, YAN Li, LI Ruichen, ZHAO Yang, WANG Xiaoshen, YANG Xuguang, ZHU Yi
Published: (2023-06-01)

An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma
by: Xiwang Zheng, et al.
Published: (2023-01-01)

Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes
by: Bin Chen, et al.
Published: (2022-09-01)

Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma
by: Maohua Liu, et al.
Published: (2023-03-01)

Identification of Exosome-Related Genes Associated with Prognosis and Immune Infiltration Features in Head-Neck Squamous Cell Carcinoma
by: Yuanhe You, et al.
Published: (2023-06-01)

A human pan-cancer system analysis of regulator of chromatin condensation 2
by: Siming Gong, et al.
Published: (2023-02-01)

Cuproptosis combines immune landscape providing prognostic biomarker in head and neck squamous carcinoma
by: Tingting Shu, et al.
Published: (2023-05-01)

AVPR2 is a potential prognostic biomarker and correlated with immune infiltration in head and neck squamous cell carcinoma
by: Linwei Mao, et al.
Published: (2023-03-01)

Prognostic Markers in Head and Neck Cancer Patients Treated with Nivolumab
by: Daisuke Nishikawa, et al.
Published: (2018-11-01)

PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment
by: Yaodong He, et al.
Published: (2023-06-01)

DCBLD1 Overexpression Is Associated With a Poor Prognosis in Head and Neck Squamous Cell Carcinoma
by: Ling-ling Fu, et al.
Published: (2022-07-01)

Comprehensive investigation into the influence of glycosylation on head and neck squamous cell carcinoma and development of a prognostic model for risk assessment and anticipating immunotherapy
by: Heng Ma, et al.
Published: (2024-03-01)

Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma
by: Ling-ling Fu, et al.
Published: (2022-11-01)

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
by: Chenhang Yu, et al.
Published: (2022-08-01)

Identification of a metabolic reprogramming‐related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis
by: Weijie Qiang, et al.
Published: (2022-08-01)